MicroRNAs as stress regulators in pancreatic beta cells and diabetes

Molecular Metabolism

Volumn 6, Issue 9, 2017, Pages 1010-1023

  LaPierre, Mary P ^a   Stoffel, Markus ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Diabetes; Insulin secretion; miRNAs; Pancreatic cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; MICRORNA; MICRORNA 124A; MICRORNA 132; MICRORNA 146; MICRORNA 148; MICRORNA 15; MICRORNA 152; MICRORNA 16; MICRORNA 184; MICRORNA 186; MICRORNA 195; MICRORNA 200; MICRORNA 203; MICRORNA 210; MICRORNA 212; MICRORNA 23; MICRORNA 27; MICRORNA 322; MICRORNA 338; MICRORNA 34; MICRORNA 375; MICRORNA 378; MICRORNA 49; MICRORNA 497; MICRORNA 7; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELL VOLUME; DIABETES MELLITUS; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENOTYPE; HORMONE SYNTHESIS; HUMAN; INDUCED PLURIPOTENT STEM CELL; INSULIN RELEASE; INSULIN RESISTANCE; NONHUMAN; NOTCH SIGNALING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL DIFFERENTIATION; GENETICS; METABOLISM; OBESITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS; HUMANS; INSULIN SECRETION; INSULIN-SECRETING CELLS; MICRORNAS; OBESITY; STRESS, PHYSIOLOGICAL;

EID: 85026329653     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2017.06.020     Document Type: Review

References (126)

1. Ha, M., Kim, V.N., Regulation of microRNA biogenesis. Nature Reviews Molecular Cell Biology 15 (2014), 509–524.
2. Agarwal, V., Bell, G.W., Nam, J.W., Bartel, D.P., Predicting effective microRNA target sites in mammalian mRNAs. eLife, 4, 2015, 4.
3. Eulalio, A., Huntzinger, E., Izaurralde, E., Getting to the root of miRNA-mediated gene silencing. Cell 132 (2008), 9–14.
4. Guo, H., Ingolia, N.T., Weissman, J.S., Bartel, D.P., Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466 (2010), 835–840.
5. Salmena, L., Poliseno, L., Tay, Y., Kats, L., Pandolfi, P.P., A ceRNA hypothesis: the Rosetta stone of a hidden RNA language?. Cell 146 (2011), 353–358.
6. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J., Pandolfi, P.P., A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465 (2010), 1033–1038.
7. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147 (2011), 358–369.
8. Fang, L., Du, W.W., Yang, X., Chen, K., Ghanekar, A., Levy, G., et al. Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB Journal 27 (2013), 907–919.
9. Denzler, R., Agarwal, V., Stefano, J., Bartel, D.P., Stoffel, M., Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Molecular Cell 54 (2014), 766–776.
10. Bosson, A.D., Zamudio, J.R., Sharp, P.A., Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition. Molecular Cell 56 (2014), 347–359.
11. Denzler, R., McGeary, S.E., Title, A.C., Agarwal, V., Bartel, D.P., Stoffel, M., Impact of MicroRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression. Molecular Cell 64 (2016), 565–579.
12. Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., et al. Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
13. Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (2013), 333–338.
14. Guo, J.U., Agarwal, V., Guo, H., Bartel, D.P., Expanded identification and characterization of mammalian circular RNAs. Genome Biology, 15, 2014, 409.
15. Poy, M.N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proceedings of the National Academy of Sciences of the United States of America 106 (2009), 5813–5818.
16. Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
17. Lynn, F.C., Skewes-Cox, P., Kosaka, Y., McManus, M.T., Harfe, B.D., German, M.S., MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56 (2007), 2938–2945.
18. Kanji, M.S., Martin, M.G., Bhushan, A., Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes 62 (2013), 1602–1611.
19. Kalis, M., Bolmeson, C., Esguerra, J.L., Gupta, S., Edlund, A., Tormo-Badia, N., et al. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One, 6, 2011, e29166.
20. Mandelbaum, A.D., Melkman-Zehavi, T., Oren, R., Kredo-Russo, S., Nir, T., Dor, Y., et al. Dysregulation of Dicer1 in beta cells impairs islet architecture and glucose metabolism. Experimental Diabetes Research, 2012, 2012, 470302.
21. Martinez-Sanchez, A., Nguyen-Tu, M.-S., Rutter, G.A., DICER inactivation identifies pancreatic β-cell “disallowed” genes targeted by microRNAs. Molecular Endocrinology 29 (2015), 1067–1079.
22. Cohen, S.M., Brennecke, J., Stark, A., Denoising feedback loops by thresholding – a new role for microRNAs. Genes & Development 20 (2006), 2769–2772.
23. Pullen, T.J., Khan, A.M., Barton, G., Butcher, S.A., Sun, G., Rutter, G.A., Identification of genes selectively disallowed in the pancreatic islet. Islets 2 (2010), 89–95.
24. Ishihara, H., Wang, H., Drewes, L.R., Wollheim, C.B., Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. Journal of Clinical Investigation 104 (1999), 1621–1629.
25. Kataoka, K., Shioda, S., Ando, K., Sakagami, K., Handa, H., Yasuda, K., Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. Journal of Molecular Endocrinology 32 (2004), 9–20.
26. Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S.E., Bottino, R., et al. PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature 478 (2011), 349–355.
27. Ginguay, A., Cynober, L., Curis, E., Nicolis, I., Ornithine aminotransferase, an important glutamate-metabolizing enzyme at the crossroads of multiple metabolic pathways. Biology (Basel), 6(1), 2017 Mar 7, 10.3390/biology6010018 pii: E18.
28. Sitar, T., Popowicz, G.M., Siwanowicz, I., Huber, R., Holak, T.A., Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proceedings of the National Academy of Sciences of the United States of America 103 (2006), 13028–13033.
29. Kameswaran, V., Bramswig, N.C., McKenna, L.B., Penn, M., Schug, J., Hand, N.J., et al. Epigenetic regulation of the DLK1-MEG3 MicroRNA cluster in human type 2 diabetic islets. Cell Metabolism 19 (2014), 135–145.
30. Roat, R., Hossain, M.M., Christopherson, J., Free, C., Jain, S., Guay, C., et al. Identification and characterization of microRNAs associated with human β-cell loss in a mouse model. American Journal of Transplantation 17 (2017), 992–1007.
31. Tattikota, S.G., Rathjen, T., McAnulty, S.J., Wessels, H.-H., Akerman, I., van de Bunt, M., et al. Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metabolism 19 (2014), 122–134.
32. Tattikota, S.G., Sury, M.D., Rathjen, T., Wessels, H.-H., Pandey, A.K., You, X., et al. Argonaute2 regulates the pancreatic β-cell secretome. Molecular & Cellular Proteomics 12 (2013), 1214–1225.
33. Nesca, V., Guay, C., Jacovetti, C., Menoud, V., Peyot, M.-L., Laybutt, D., et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:10 (2013), 2203–2212.
34. Zhao, E., Keller, M.P., Rabaglia, M.E., Oler, A.T., Stapleton, D.S., Schueler, K.L., et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mammalian Genome 20 (2009), 476–485.
35. Roggli, E., Gattesco, S., Caille, D., Briet, C., Boitard, C., Meda, P., et al. Changes in MicroRNA expression contribute to pancreatic b-cell dysfunction in prediabetic NOD mice. Diabetes 61:7 (2012), 1742–1751.
36. Grieco, F.A., Sebastiani, G., Juan-Mateu, J., Villate, O., Marroqui, L., Ladrière, L., et al. MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149 5p regulate the expression of proapoptotic BH3 only proteins DP5 and PUMA in human pancreatic β-cells. Diabetes 66 (2017), 100–112.
37. Bravo-Egana, V., Rosero, S., Klein, D., Jiang, Z., Vargas, N., Tsinoremas, N., et al. Inflammation-mediated regulation of MicroRNA expression in transplanted pancreatic islets. Journal of Transplantation 2012 (2012), 1–15.
38. Locke, J.M., Da Silva Xavier, G., Dawe, H.R., Rutter, G.A., Harries, L.W., Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 57 (2014), 122–128.
39. Git, A., Dvinge, H., Salmon-Divon, M., Osborne, M., Kutter, C., Hadfield, J., et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16 (2010), 991–1006.
40. Buitrago, D.H., Patnaik, S.K., Kadota, K., Kannisto, E., Jone, D.R., Adusumilli, P.S., Small RNA sequencing for profiling microRNAs in long-term preserved formalin-fixed and paraffin-embedded non-small cell lung cancer tumor specimens. PLoS One 10 (2015), 1–12.
41. Melkman-Zehavi, T., Oren, R., Kredo-Russo, S., Shapira, T., Mandelbaum, A.D., Rivkin, N., et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. The EMBO Journal 30 (2011), 835–845.
42. Zeng, X., Huang, C., Senavirathna, L., Wang, P., Liu, L., miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway. BMC Cell Biology, 18, 2017, 9.
43. Bolmeson, C., Esguerra, J.L., Salehi, A., Speidel, D., Eliasson, L., Cilio, C.M., Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. Biochemical and Biophysical Research 404 (2011), 16–22.
44. Frost, R.J., Olson, E.M., Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proceedings of the National Academy of Sciences of the United States of America 108 (2011), 21075–21080.
45. Zhu, H., Shyh-Chang, N., Segrè, A.V., Shinoda, G., Shah, S.P., Einhorn, W.S., et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 147 (2011), 81–94.
46. Ouaamari, E.I., Baroukh, N., Martens, G.A., Lebrun, P., Pipeleers, D., van Obberghen, E., miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57 (2008), 2708–2717.
47. Latreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M.T., McCarthy, M.I., et al. miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development. Journal of Molecular Medicine (Berlin) 93 (2015), 1159–1169.
48. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007), 1401–1414.
49. Ahmed, K., LaPierre, M.P., Gasser, E., Denzler, R., Yang, Y., Rülicke, T., et al. Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility. Journal of Clinical Investigation 127 (2017), 1061–1074.
50. Xu, H., Guo, S., Li, W., Yu, P., The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Scientific Reports, 5, 2015, 12453.
51. Latreille, M., Hausser, J., Stützer, I., Zhang, Q., Hastoy, B., Gargani, S., et al. MicroRNA-7a regulates pancreatic β cell function. Journal of Clinical Investigation 124 (2014), 2722–2735.
52. Esguerra, J.L., Bolmeson, C., Cilio, C.M., Eliasson, L., Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One, 6, 2011, e18613.
53. Kredo-Russo, S., Mandelbaum, A.D., Ness, A., Alon, I., Lennox, K.A., Behlke, M.A., et al. Pancreas enriched miRNA refines endocrine cell differentiation. Development 139 (2012), 3021–3031.
54. Lang, H., Ai, Z., You, Z., Wan, Y., Guo, W., Xiao, J., et al. Characterization of miR-218/322-Stxbp1 pathway in the process of insulin secretion. Journal of Molecular Endocrinology 54 (2015), 65–73.
55. Bagge, A., Dahmcke, C.M., Dalgaard, L.T., Syntaxin-1a is a direct target of miR-29a in insulin-producing β-cells. Syntaxin-1a is a direct target of miR-29a in insulin-producing β-cells. Hormone and Metabolic Research 45 (2013), 463–466.
56. Plaisance, V., Abderrahmani, A., Perret-Menoud, V., Jacquemin, P., Lemaigre, F., Regazzi, R., MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. Journal of Biological Chemistry 281 (2006), 26932–26942.
57. Porte, D. Jr., Kahn, S.E., β-Cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50:Suppl. 1 (2001), S160–S163.
58. Vinod, M., Patankar, J.V., Sachdev, V., Frank, S., Graier, W.F., Kratky, D., et al. MiR-206 is expressed in pancreatic islets and regulates glucokinase activity. American Journal of Physiology Endocrinology and Metabolism 311 (2016), E175–E185.
59. Tattikota, S.G., Rathjen, T., Hausser, J., Khedkar, A., Kabra, U.D., Pandey, V., et al. miR-184 regulates pancreatic β-cell function according to glucose metabolism. Journal of Biological Chemistry 290 (2015), 20284–20294.
60. Setyowati Karolina, D., Sepramaniam, S., Tan, H.Z., Armugam, A., Jeyaseelan, K., miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA Biology 10 (2013), 1365–1378.
61. Zhu, Y., You, W., Wang, H., Li, Y., Qiao, N., Shi, Y., et al. MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction. Diabetes 62 (2013), 3194–3206.
62. Kim, J.W., You, Y.H., Jung, S., Suh-Kim, H., Lee, I.K., Cho, J.H., et al. miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models. Diabetologia 56 (2013), 847–855.
63. Xu, G., Chen, J., Jing, G., Shalev, A., Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nature Medicine 19 (2013), 1141–1146.
64. Baroukh, N., Ravier, M.A., Loder, M.K., Hill, E.V., Bounacer, A., Scharfmann, R., et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. Journal of Biological Chemistry 282 (2007), 19575–19588.
65. Poy, M.N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004), 226–230.
66. Backe, M.B., Novotny, G.W., Christensen, D.P., Grunnet, L.G., Mandrup-Poulsen, T., Altering β-cell number through stable alteration of miR-21 and miR-34a expression. Islets, 6, 2014, e27754.
67. Tsukita, S., Yamada, T., Takahashi, K., Munakata, Y., Hosaka, S., Takahashi, H., et al. MicroRNAs 106b and 222 improve hyperglycemia in a mouse model of insulin-deficient diabetes via pancreatic β-cell proliferation. EBioMedicine 15 (2017), 163–172.
68. Tao, H., Wang, M.M., Zhang, M., Zhang, S.P., Wang, C.H., Yuan, W.J., et al. MiR-126 suppresses the glucose-stimulated proliferation via IRS-2 in INS-1 β cells. PLoS One, 11, 2016, e0149954.
69. Lu, Y., Fei, X.Q., Yang, S.F., Xu, B.K., Li, Y.Y., Glucose-induced microRNA-17 promotes pancreatic beta cell proliferation through down-regulation of Menin. European Review for Medical and Pharmacological Sciences 19 (2015), 624–629.
70. Jacovetti, C., Jimenez, V., Ayuso, E., Laybutt, R., Peyot, M.L., Prentki, M., et al. Contribution of intronic miR-338-3p and its hosting gene AATK to compensatory β-cell mass expansion. Molecular Endocrinology 29 (2015), 693–702.
71. Cnop, M., Welsh, N., Jonas, J.C., Jörns, A., Lenzen, S., Eizirik, D.L., Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54:Suppl. 2 (2005), S97–S107.
72. Halban, P.A., Polonsky, K.S., Bowden, D.W., Hawkins, M.A., Ling, C., Mather, K.J., et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Journal of Clinical Endocrinology & Metabolism 99 (2014), 1983–1992.
73. Schickel, R., Park, S.M., Murmann, A.E., Peter, M.E., miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Molecular Cell 38 (2010), 908–915.
74. Filios, S.R., Xu, G., Chen, J., Hong, K., Jing, G., Shalev, A., MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. J Biol Chem 289 (2014), 36275–36283.
75. Wang, Y., Li, D., Luo, J., Tian, G., Zhao, L.Y., Liao, D., Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis. Scientific Reports, 6, 2016, 37213.
76. Xiao, Y., Yan, W., Lu, L., Wang, Y., Lu, W., Cao, Y., et al. p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death. Cell Cycle 14 (2015), 1548–1558.
77. Belgardt, B.F., Ahmed, K., Spranger, M., Latreille, M., Denzler, R., Kondratiuk, N., et al. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nature Medicine 21 (2015), 619–627.
78. Hong, K., Xu, G., Grayson, T.B., Shalev, A., Cytokines regulate β-cell thioredoxin-interacting protein (TXNIP) via distinct mechanisms and pathways. Journal of Biological Chemistry 291 (2016), 8428–8439.
79. Lerner, A.G., Upton, J.P., Praveen, P.V., Ghosh, R., Nakagawa, Y., Igbaria, A., et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metabolism 16 (2012), 250–264.
80. Zheng, Y., Wang, Z., Tu, Y., Shen, H., Dai, Z., Lin, J., et al. miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction. Laboratory Investigation 95 (2015), 1387–1397.
81. Li, Y., Luo, T., Wang, L., Wu, J., Guo, S., MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3. International Journal of Molecular Medicine 38 (2016), 1515–1524.
82. Mohan, R., Mao, Y., Zhang, S., Zhang, Y.W., Xu, C.R., Gradwohl, G., et al. Differentially expressed MicroRNA-483 confers distinct functions in pancreatic β- and α-cells. Journal of Biological Chemistry 290 (2015), 19955–19966.
83. Bao, L., Fu, X., Si, M., Wang, Y., Ma, R., Ren, X., et al. MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PLoS One, 10, 2015, e0116067.
84. Neel, J.V., Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”?. American Journal of Human Genetics 14 (1962), 353–362.
85. Shafrir, E., Ziv, E., Kalman, R., Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR Journal 47 (2006), 212–224.
86. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 10513–10518.
87. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 18 (2008), 997–1006.
88. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signalling, 2, 2009, ra81.
89. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9 (2007), 654–659.
90. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America 108 (2011), 5003–5008.
91. Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D., Remaley, A.T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology 13 (2011), 423–433.
92. Thomou, T., Mori, M.A., Dreyfuss, J.M., Konishi, M., Sakaguchi, M., Wolfrum, C., et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542 (2017), 450–455.
93. Williams, Z., Ben-Dov, I.Z., Elias, R., Mihailovic, A., Brown, M., Rosenwaks, Z., et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proceedings of the National Academy of Sciences of the United States of America 110 (2013), 4255–4260.
94. Neal, C.S., Michael, M.Z., Pimlott, L.K., Yong, T.Y., Li, J.Y.Z., Gleadle, J.M., Circulating microRNA expression is reduced in chronic kidney disease. Nephrology Dialysis Transplantation 26 (2011), 3794–3802.
95. Guay, C., Regazzi, R., Circulating microRNAs as novel biomarkers for diabetes mellitus. Nature Reviews Endocrinology 9 (2013), 513–521.
96. Erener, S., Mojibian, M., Fox, J.K., Denroche, H.C., Kieffer, T.J., Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology 154 (2013), 603–608.
97. Chappell, J., Watters, K.E., Takahashi, M.K., Lucks, J.B., A renaissance in RNA synthetic biology: new mechanisms, applications and tools for the future. Current Opinion in Chemical Biology 28 (2015), 47–56.
98. Cullen, B.R., Viral and cellular messenger RNA targets of viral microRNAs. Nature 457 (2009), 421–425.
99. Boudreau, R.L., Martins, I., Davidson, B.L., Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Molecular Therapy 17 (2009), 169–175.
100. Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. MicroRNA-133 controls cardiac hypertrophy. Nature Medicine 13 (2007), 613–618.
101. Ebert, M.S., Neilson, J.R., Sharp, P.A., MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4 (2007), 721–726.
102. Franco-Zorrilla, J.M., Valli, A., Todesco, M., Mateos, I., Puga, M.I., Rubio-Somoza, I., et al. Target mimicry provides a new mechanism for regulation of microRNA activity. Nature Genetics 39 (2007), 1033–1037.
103. Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M., et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438 (2005), 685–689.
104. Krützfeldt, J., Kuwajima, S., Braich, R., Rajeev, K.G., Pena, J., Tuschl, T., et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Research 35 (2007), 2885–2892.
105. Wolfrum, C., Shi, S., Jayaprakash, K.N., Jayaraman, M., Wang, G., Pandey, R.K., et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology 25 (2007), 1149–1157.
106. Ameres, S.L., Horwich, M.D., Hung, J.H., Xu, J., Ghildiyal, M., Weng, Z., et al. Target RNA-directed trimming and tailing of small silencing RNAs. Science 328 (2010), 1534–1539.
107. Ameres, S.L., Phillip, D., Zamore, P., Diversifying microRNA sequence and function. Nature Reviews Molecular Cell Biology 14 (2013), 475–488.
108. Davis, S., Lollo, B., Freier, S., Esau, C., Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Research 34 (2006), 2294–2304.
109. Ørom, U.A., Kauppinen, S., Lund, A.H., LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372 (2006), 137–141.
110. Lennox, K.A., Behlke, M.A., A direct comparison of anti-microRNA oligonucleotide potency. Journal of Pharmacy Research 27 (2010), 1788–1799.
111. Maekawa, M., Yamaguchi, K., Nakamura, T., Shibukawa, R., Kodanaka, I., Ichisaka, T., et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474 (2011), 225–229.
112. Lahmy, R., Soleimani, M., Sanati, M.H., Behmanesh, M., Kouhkan, F., Mobarra, N., MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells. Molecular Biology Reports 41 (2014), 2055–2066.
113. Shaer, A., Azarpira, N., Karimi, M.H., Differentiation of human induced pluripotent stem cells into insulin-like cell clusters with miR-186 and miR-375 by using chemical transfection. Applied Biochemistry and Biotechnology 174 (2014), 242–258.
114. Liang, D., Zhang, Y., Han, J., Wang, W., Liu, Y., Li, J., et al. Embryonic stem cell-derived pancreatic endoderm transplant with MCT1-suppressing miR-495 attenuates type II diabetes in mice. Endocrine Journal 62 (2015), 907–920.
115. Mi, Y., Guo, N., He, T., Ji, J., Li, Z., Huang, P., miR-410 enhanced hESC-derived pancreatic endoderm transplant to alleviate gestational diabetes mellitus. Journal of Molecular Endocrinology 55 (2015), 219–229.
116. Zhao, X., Mohan, R., Özcan, S., Tang, X., MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. Journal of Biological Chemistry 287 (2012), 31155–31164.
117. Tang, X., Muniappan, L., Tang, G., Özcan, S., Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 15 (2009), 287–293.
118. Sebastiani, G., Po, A., Miele, E., Ventriglia, G., Ceccarelli, E., Bugliani, M., et al. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetologica 52 (2015), 523–530.
119. Salunkhe, V.A., Esguerra, J.L., Ofori, J.K., Mollet, I.G., Braun, M., Stoffel, M., et al. Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells. Acta Physiologica (Oxford) 213 (2015), 882–892.
120. Roggli, E., Britan, A., Gattesco, S., Lin-Marg, N., Abderrahmani, A., Meda, P., et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59 (2010), 978–986.
121. Shang, J., Li, J., Keller, M.P., Hohmeier, H.E., Wang, Y., Feng, Y., et al. Induction of miR-132 and miR-212 expression by glucagon-like peptide 1 (GLP-1) in rodent and human pancreatic β-cells. Molecular Endocrinology 29 (2015), 1243–1253.
122. Wang, Y., Liu, J., Liu, C., Naji, A., Stoffers, D.A., MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. Diabetes 62 (2013), 887–895.
123. Ofori, J.K., Salunkhe, V.A., Bagge, A., Vishnu, N., Nagao, M., Mulder, H., Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell. Scientific Reports, 7, 2017, 44986.
124. Pullen, T.J., da Silva Xavier, G., Kelsey, G., Rutter, G.A., miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Molecular and Cellular Biology 31 (2011), 3182–3194.
125. Kang, M.H., Zhang, L.H., Wijesekara, N., de Haan, W., Butland, S., Bhattacharjee, A., et al. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arteriosclerosis Thrombosis and Vascular Biology 33 (2013), 2724–2732.
126. Wijesekara, N., Zhang, L.H., Kang, M.H., Abraham, T., Bhattacharjee, A., Warnock, G.L., et al. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes 61 (2012), 653–658.